Shulgan Myron W.
SEC CIK 2038614 · EDGAR
Most active insiders at DMII, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Drugs Made In America Acquisition II LLC | 10% | — | — |
| 2 | Do Catherine | Dir | — | — |
| 3 | Shulgan Myron W. | Dir | — | — |
| 4 | Prasad Sridhar G. | Dir | — | — |
| 5 | Stockwell Lynn | CEO, Exe. COB of Board, Dir, 10% | — | — |
| 6 | Worman Glenn C. | CFO | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-02 | 2025-09-26 | DMII | Drugs Made In America Acquisition II Corp. | Shulgan Myron W. | Dir | J - Other | — | +100.0K | 100.0K | New | — | |
| 2025-02-03 | 2025-01-29 | DMAA | Drugs Made In America Acquisition Corp. | Shulgan Myron W. | Dir | J - Other | — | +100.0K | 100.0K | New | — |
Purchase Sale Sale after option exercise All abbreviations